Primary CNS Lymphoma

por Phillips, Elizabeth H., Fox, Christopher P., Cwynarski, Kate
Publicado 2014

P1223: IMAGING MASS CYTOMETRY REVEALS A HIGHLY HETEROGENOUS CELL MAKEUP AND SPATIAL CONTEXT OF THE FOLLICULAR LYMPHOMA TUMOR MICROENVIRONMENT

por Patten, Piers, Buckley, Paul, Chan, Julie, Jouvin, Laura, Bishop, Cynthia, Todd, Katrina, Phillips, Elizabeth H., Bottos, Alessia
Publicado 2023

The architecture of neoplastic follicles in follicular lymphoma; analysis of the relationship between the tumor and follicular helper T cells

por Townsend, William, Pasikowska, Marta, Yallop, Deborah, Phillips, Elizabeth H., Patten, Piers E.M., Salisbury, Jonathan R., Marcus, Robert, Pepper, Andrea, Devereux, Stephen
Publicado 2020

In vitro and in vivo evidence for uncoupling of B-cell receptor internalization and signaling in chronic lymphocytic leukemia

por Coulter, Eve M., Pepper, Andrea, Mele, Silvia, Folarin, Najeem’deen, Townsend, William, Cuthill, Kirsty, Phillips, Elizabeth H., Patten, Piers E. M., Devereux, Stephen
Publicado 2018

PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA...

por Vitolo, Umberto, Phillips, Elizabeth H., Alonso, Aránzazu Alonso, Merli, Michele, Risal, Ashish, Namuduri, Manjusha, Shen, Biyi, Flink, Dina, Zhu, Min, Mukherjee, Sushmita, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Mohamed, Hesham, Ambati, Srikanth, Cordoba, Raul
Publicado 2023

Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial

por Phillips, Elizabeth H., Burton, Catherine, Kirkwood, Amy A., Barrans, Sharon, Lawrie, Anthony, Rule, Simon, Patmore, Russell, Pettengell, Ruth, Ardeshna, Kirit M., Montoto, Silvia, Paneesha, Shankara, Clifton‐Hadley, Laura, Linch, David C., McMillan, Andrew K.
Publicado 2020

Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study

por Townsend, William, Hiddemann, Wolfgang, Buske, Christian, Cartron, Guillaume, Cunningham, David, Dyer, Martin J.S., Gribben, John G., Phillips, Elizabeth H., Dreyling, Martin, Seymour, John F., Grigg, Andrew, Trotman, Judith, Lin, Tong-Yu, Hong, Xiao-Nan, Kingbiel, Dirk, Nielsen, Tina G., Knapp, Andrea, Herold, Michael, Marcus, Robert
Publicado 2023

P1211: TUMOR-ACTIVATED LYMPH NODE FIBROBLASTS SUPPRESS T CELL FUNCTION IN DIFFUSE LARGE B CELL LYMPHOMA

por Apollonio, Benedetta, Spada, Filomena, Petrov, Nedyalko, Cozzetto, Domenico, Jarvis, Peter, Papazoglou, Despoina, Kannambath, Shichina, Terranova-Barberio, Manuela, Amini, Rose-Marie, Enblad, Gunilla, Graham, Charlotte, Benjamin, Reuben, Phillips, Elizabeth H., Ellis, Richard, Nuamah, Rosamond, Saqi, Mansoor, Calado, Dinis, Rosenquist, Richard, Ann Sutton, Lesley, Salisbury, Jon, Zacharioudakis, Georgios, Vardi, Anna, Hagner, Patrick, Gandhi, Anita, Bacac, Marina, Claus, Christina, Umana, Pablo, Jarrett, Ruth, Klein, Christian, Deutsch, Alexander, Ramsay, Alan
Publicado 2023

Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL

por Northend, Michael, Wilson, William, Osborne, Wendy, Fox, Christopher P., Davies, Andrew J., El-Sharkawi, Dima, Phillips, Elizabeth H., Sim, Hau Wui, Sadullah, Shalal, Shah, Nimish, Peng, Ying Ying, Qureshi, Iman, Addada, Juanah, Mora, Rocio Figueroa, Phillips, Neil, Kuhnl, Andrea, Davies, Elizabeth, Wrench, David, McKay, Pamela, Karpha, Indrani, Cowley, Anna, Karim, Richard, Challenor, Sarah, Singh, Vikram, Burton, Cathy, Auer, Rebecca, Williams, Chris, Cunningham, Joel, Broom, Angus, Arasaretnam, Anita, Roddie, Claire, Menne, Tobias, Townsend, William
Publicado 2022